Literature DB >> 20079490

[Hepatic cell transplantation. Technical and methodological aspects].

Eugenia Pareja1, Amparo Martínez, Miriam Cortés, Ana Bonora, Angel Moya, Fernando Sanjuán, M José Gómez-Lechón, José Mir.   

Abstract

Hepatic cell transplantation consists of grafting already differentiated cells such as hepatocytes. Human hepatocytes are viable and functionally active. Liver cell transplantation is carried out by means of a 3-step method: isolation of hepatocytes from donor liver rejected for orthotopic transplantation, preparing a cell suspension for infusion and, finally, hepatocytes are implanted into the recipient. There are established protocols for the isolation of human hepatocytes from unused segments of donor livers, based on collagenase digestion of cannulated liver tissue at 37 degrees C. The hepatocytes can be used fresh or cryopreserved. Cryopreservation of isolated human hepatocytes would then be available for planned use. In cell transplant, the important aspects are: infusion route, number of cells, number of infusions and viability of the cells. The cells are infused into the patient through a catheter inserted via portal vein or splenic artery. Liver cell transplantation allows liver tissue to be used that would, otherwise, be discarded, enabling multiple patients to be treated with hepatocytes from a single tissue donor. Copyright 2009 AEC. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20079490     DOI: 10.1016/j.ciresp.2009.10.002

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  2 in total

Review 1.  Hepatocyte transplantation program: Lessons learned and future strategies.

Authors:  Eugenia Pareja Ibars; Miriam Cortes; Laia Tolosa; Maria José Gómez-Lechón; Slivia López; José Vicente Castell; José Mir
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

2.  The use of cellular technologies in treatment of liver pathologies.

Authors:  O S Petrakova; E S Chernioglo; V V Terskikh; E N Kalistratova; A V Vasiliev
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.